Mission Statement and Goals of the South African Glaucoma Society (SAGS)

To optimise the quality of glaucoma care in South Africa through communication and co-operation amongst General Practitioners, Optometrists, Ophthalmologists and Glaucomatologists with Glaucoma Industries, Glaucoma Patient Organizations and all other major players in the glaucoma field. We have a shared goal: The Quality of Life of the Glaucoma Patient.

Governance and Responsibility of South African Glaucoma Society:
The Executive Committee, the President of SAGS and 6 Executive Members convene the Annual General Meeting at the annual SAGS Congress, have regular executive meetings, co-operate with International Glaucoma Societies in America (AGS), Europe (EGS), Africa (SAG), Australia and the Far East (SEAG), co-operate with Glaucoma Industries, adhere to the World Glaucoma Association (WGA) Code of Practice, guidelines for conduct of meetings, direct profits from official meetings go to the Society (www.glaucom.com) and communicate via electronic means of email. Secretary to SAGS: Charmaine Watkins - contact details: tel: 011-468 5339   fax: 086 649 2355  email: charmaine@sags.co.za

Membership Criteria:
Members of South African Glaucoma Society (SAGS) are either full member (private practice or academic); associate member (resident or student member); corresponding member, honorary or life member. Members are committed to the mission of SAGS, to action needed to realise these goals and to active communication. 


Patient Information

Patients information image

The goal of glaucoma treatment is the preservation of visual function and quality of life, with minimal or no side effects, with minimal disruption to the normal activities of a glaucoma patient, at a sustainable cost to the patient and the health provider
Read more »

Doctors Information

Doctors information image

The South African Glaucoma Society aims to optimise the quality of glaucoma care in South Africa. Our management goal is the preservation of visual function adequate to the individual needs with minimal or no side effects, for the expected life time of the patient, without any disruption of his/her normal activities, at a sustainable cost.
Read more »